FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1513981000168108: Laceraine Topical Wound Anaesthetic (epinephrine acid tartrate 7.2 mg / 4 mL + lidocaine hydrochloride monohydrate 170 mg / 4 mL + tetracaine hydrochloride 20 mg / 4 mL) gel, 4 mL vial (trade product unit of use)

    Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module

    Descriptions:

    Id Description Lang Type Status Case? Module
    4500861000168114 Laceraine Topical Wound Anaesthetic (epinephrine acid tartrate 7.2 mg / 4 mL + lidocaine hydrochloride monohydrate 170 mg / 4 mL + tetracaine hydrochloride 20 mg / 4 mL) gel, 4 mL vial (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
    4500871000168115 Laceraine Topical Wound Anaesthetic gel, 4 mL vial en Synonym Active Case sensitive Australian Medicines Terminology module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Laceraine Topical Wound Anaesthetic gel, 4 mL vial Is a Laceraine Topical Wound Anaesthetic false Inferred relationship Some
    Laceraine Topical Wound Anaesthetic gel, 4 mL vial Is a adrenaline (epinephrine) acid tartrate 0.18% + tetracaine (amethocaine) hydrochloride 0.5% + lidocaine (lignocaine) hydrochloride monohydrate 4.25% gel, vial false Inferred relationship Some
    Laceraine Topical Wound Anaesthetic gel, 4 mL vial Is a trade product unit of use false Inferred relationship Some
    Laceraine Topical Wound Anaesthetic gel, 4 mL vial has manufactured dose form gel false Inferred relationship Some
    Laceraine Topical Wound Anaesthetic gel, 4 mL vial has Australian BoSS lidocaine hydrochloride monohydrate false Inferred relationship Some 891635879
    Laceraine Topical Wound Anaesthetic gel, 4 mL vial has intended active ingredient lidocaine false Inferred relationship Some 891635879
    Laceraine Topical Wound Anaesthetic gel, 4 mL vial has unit of use vial false Inferred relationship Some 1348660361
    Laceraine Topical Wound Anaesthetic gel, 4 mL vial has Australian BoSS tetracaine hydrochloride (AU substance) false Inferred relationship Some 1139742040
    Laceraine Topical Wound Anaesthetic gel, 4 mL vial has intended active ingredient tetracaine (amethocaine) false Inferred relationship Some 1139742040
    Laceraine Topical Wound Anaesthetic gel, 4 mL vial has intended active ingredient adrenaline (epinephrine) false Inferred relationship Some 410367494
    Laceraine Topical Wound Anaesthetic gel, 4 mL vial has Australian BoSS adrenaline (epinephrine) acid tartrate false Inferred relationship Some 410367494
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Laceraine Topical Wound Anaesthetic gel, 5 x 4 mL vials has TPUU False Laceraine Topical Wound Anaesthetic gel, 4 mL vial Inferred relationship Some 1570593264
    Laceraine Topical Wound Anaesthetic gel, 5 x 4 mL vials has TPUU False Laceraine Topical Wound Anaesthetic gel, 4 mL vial Inferred relationship Some 144427858

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set

    Back to Start